GSK plc
GSK
#235
Rank
NZ$172.04 B
Marketcap
NZ$85.90
Share price
1.09%
Change (1 day)
30.02%
Change (1 year)

EPS for GSK plc (GSK)

EPS in 2026 (TTM): NZ$6.64

According to GSK plc's latest financial reports the company's current EPS (TTM) is NZ$6.57. In 2025 the company made an earnings per share (EPS) of NZ$6.37 an increase over its 2024 EPS that were of NZ$2.69.

EPS history for GSK plc from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$6.644.22%
2025NZ$6.37136.36%
2024NZ$2.69-47.35%
2023NZ$5.12-64.2%
2022NZ$14.30182.29%
2021NZ$5.06-18.07%
2020NZ$6.1822.34%
2019NZ$5.0523.9%
2018NZ$4.08140.61%
2017NZ$1.7064.45%
2016NZ$1.03-90.61%
2015NZ$10.97178.12%
2014NZ$3.95-48.11%
2013NZ$7.6022.68%
2012NZ$6.20-11.31%
2011NZ$6.99

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
NZ$11.87 80.63%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.21-66.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$4.33-34.14%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
NZ$6.04-8.01%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$11.75 78.83%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$2.32-64.75%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Dynavax Technologies
DVAX
NZ-$0.54-108.23%๐Ÿ‡บ๐Ÿ‡ธ USA